Analyst Ratings for Amedisys (AMED) [Neutrals]
AMED Rating Summary
AMED Price Target Summary
- Highest: $101.00 (Jefferies)
- Lowest: $73.00 (UBS)
- Average: $95.30
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$95.30 (+4.5%)
* Over Last 12-Mos
Rating Score: 3.5 / 10
Percentile Rank: 33%
Avg. $ Target:
$95.30 (+4.5%)
* Over Last 12-Mos
Rating Score: 3.5 / 10
Percentile Rank: 33%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 7/6/2023 | Jefferies | Brian Tanquilut | Downgrade | Hold (Buy) |
101.00 (98.00) |
91.35 (91.16) |
-0.21% | Details |
| 6/27/2023 | Benchmark | Bill Sutherland | Downgrade | Hold (Buy) |
N/A (N/A) |
91.00 (91.16) |
0.18% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
